RMD Q2 2023 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

Q2 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$1.0B+15.5% YoY

Gross Profit

$580M56.1% margin

Operating Income

$280M27.1% margin

Net Income

$225M21.8% margin

EPS (Diluted)

$1.53

QoQ Revenue Growth

+8.8%

Cash Flow

Operating Cash Flow

$129M

Free Cash Flow

$97M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$6.7B

Total Liabilities

$2.9B

Stockholders' Equity

$3.7B

Cash & Equivalents

$253M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.0B	$895M	+15.5%
Gross Profit	$580M	$504M	+15.0%
Operating Income	$280M	$249M	+12.7%
Net Income	$225M	$202M	+11.5%

Revenue Segments

Sleep And Respiratory

$917M89%

Software As Service

$117M11%

Geographic Segments

Us Canada And Latin America

$615M60%

Combined Europe Asia And Other Markets

$302M29%

Software As Service

$117M11%